Comment
. 2007 Oct;47(4):618-9; author reply 619-20.
doi: 10.1016/j.jhep.2007.07.013.
Epub 2007 Jul 27.
Adefovir for lamivudine resistant HBV: more than meets the eye
- PMID: 17697727
- DOI: 10.1016/j.jhep.2007.07.013
Item in Clipboard
Comment
Adefovir for lamivudine resistant HBV: more than meets the eye
J Hepatol.
2007 Oct.
No abstract available
Comment on
-
Viral genotype and baseline load predict the response to adefovir treatment in lamivudine-resistant chronic hepatitis B patients.J Hepatol. 2007 Sep;47(3):366-72. doi: 10.1016/j.jhep.2007.04.011. Epub 2007 May 24. J Hepatol. 2007. PMID: 17561304
Similar articles
-
Adefovir dipivoxil treatment of lamivudine-resistant chronic hepatitis B.Antiviral Res. 2007 Aug;75(2):146-51. doi: 10.1016/j.antiviral.2007.02.003. Epub 2007 Mar 16. Antiviral Res. 2007. PMID: 17400303 Clinical Trial.
-
HBV DNA level at 24 weeks is the best predictor of virological response to adefovir add-on therapy in patients with lamivudine resistance.Antivir Ther. 2012;17(2):387-94. doi: 10.3851/IMP1945. Epub 2011 Nov 2. Antivir Ther. 2012. PMID: 22293395
-
Efficacy of entecavir in patients with chronic hepatitis B resistant to both lamivudine and adefovir or to lamivudine alone.Hepatology. 2009 Oct;50(4):1064-71. doi: 10.1002/hep.23145. Hepatology. 2009. PMID: 19637288 Clinical Trial.
-
Treatment of patients with chronic hepatitis B with adefovir dipivoxil.Semin Liver Dis. 2004;24 Suppl 1:37-44. doi: 10.1055/s-2004-828677. Semin Liver Dis. 2004. PMID: 15192800 Review.
-
[Therapy for chronic hepatitis B: relationship between HBV genotype and efficacy or resistance of anti-viral therapy].Nihon Shokakibyo Gakkai Zasshi. 2007 Oct;104(10):1459-64. Nihon Shokakibyo Gakkai Zasshi. 2007. PMID: 17917393 Review. Japanese. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
